Small-Cap REIT ETF ...
Health Care: Drugs
InterMune Inc. (ITMN: NASDAQ)
$9.99 -0.31 | -3.01%
05/17/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 110.75M | 177.43M | 110.58M | 17.01M |
| Receivables | 6.77M | 3.76M | 1.71M | 3.83M |
| Inventories | 10.02M | 6.22M | 1.15M | 2.57M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 331.65M | 443.14M | 301.54M | 96.59M |
| Property, Plant & Equipment, Gross | 32.07M | 28.87M | 27.11M | 26.83M |
| Accumulated Depreciation & Depletion | 27.74M | 26.53M | 25.86M | 23.47M |
| Property, Plant & Equipment, Net | 4.33M | 2.34M | 1.25M | 3.35M |
| Intangibles | 18.25M | 19.25M | 0.00 | 0.00 |
| Other Non-Current Assets | 9.23M | 7.89M | 2.36M | 14.79M |
| Total Non-Current Assets | 31.82M | 29.48M | 3.60M | 18.14M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 363.47M | 472.62M | 305.15M | 114.73M |
| Accounts Payable | 18.89M | 10.56M | 7.99M | 12.44M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 2.58M | 874.00K | 44.30M | 8.62M |
| Total Current Liabilities | 56.67M | 34.09M | 70.06M | 37.07M |
| Long Term Debt | 240.25M | 240.25M | 85.00M | 125.52M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 228.00K | 114.00K | 786.00K | 57.94M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 240.48M | 240.36M | 85.79M | 183.46M |
| Total Liabilities | 297.15M | 274.46M | 155.85M | 220.53M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 66.32M | 198.17M | 149.30M | -105.80M |
| Common Par | 66.00K | 65.00K | 57.00K | 47.00K |
| Additional Paid In Capital | 1.16B | 1.14B | 942.38M | 808.05M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -1.10B | -947.87M | -793.10M | -915.47M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 501.00K | 1.02M | -37.00K | 1.58M |
| Total Capitalization | 306.57M | 438.42M | 234.30M | 19.72M |
| Total Equity | 66.32M | 198.17M | 149.30M | -105.80M |
| Total Liabilities & Stock Equity | 363.47M | 472.62M | 305.15M | 114.73M |
| Total Common Shares Outstanding | 66.05M | 65.30M | 56.59M | 46.67M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 65.18M | 60.10M | 54.20M | 44.35M |
| Diluted Weighted Shares Outstanding | 65.18M | 60.10M | 61.38M | 44.35M |
| Number of Employees | 269 | 201 | 105 | 121 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with ITMN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- UserChopped Liver
- ContributorHot Biotech Stocks Traded b...
- ContributorMost-Searched Stocks for th...
- Userskyisfalling
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- Contributor5 Biotech Stocks for 2012
- Contributor3 Health Care Stocks That C...
Latest ITMN Headlines from TheStreet
- ITMN Crosses Above Key Moving Average Level 04.29.13 | 04:04 pm
- J.P. Morgan Healthcare Confab Live Blog Day Three 01.09.13 | 10:01 am
- SAC's InterMune Trade Probe May Reveal Corrupted FDA Drug Review 12.10.12 | 02:12 pm
- 7 Stocks Under $10 Making Large Upside Moves 11.23.12 | 12:11 pm
- 4 Health Care Stocks Under $10 Spiking Higher 10.17.12 | 02:10 pm
- Market Preview: A Rally on Fumes 10.02.12 | 05:10 pm
- InterMune's CEO Discusses France's Economic Committee's (CEPS) Authorization Of Reimbursement Of Esbriet Conference (Transcript) 09.11.12 | 06:09 pm
- Analysts' Actions: HD SBUX MUR WAG CVS 08.15.12 | 09:08 am
- InterMune's CEO Discusses Q2 2012 Earnings - Earnings Call Transcript 07.23.12 | 02:07 pm
- Verizon, InterMune: Market Movers 07.23.12 | 12:07 pm
Press Releases for ITMN
- InterMune To Release First Quarter Financial Results On April 24 - PR Newswire 04.17.13 | 08:04 am
- Esbriet® (pirfenidone) Receives Positive Final Appraisal Determination From NICE For Idiopathic Pulmonary Fibrosis (IPF) - PR Newswire 03.20.13 | 09:03 pm
- Sean P. Nolan Joins InterMune As Executive Vice President And Chief Business Officer - PR Newswire 02.14.13 | 04:02 pm
- InterMune To Release Fourth Quarter Financial Results On February 21 - PR Newswire 02.11.13 | 08:02 am
- InterMune Announces Pricing Of Concurrent Public Offerings Of $105,000,000 Principal Amount Of Convertible Senior Notes And 13,500,000 Shares Of Common Stock - PR Newswire 01.16.13 | 01:01 am
- InterMune Announces Proposed Concurrent Public Offerings Of Common Stock And Convertible Debt - PR Newswire 01.14.13 | 04:01 pm
- InterMune Reports Preliminary Fourth Quarter 2012 Esbriet® (pirfenidone) Revenue And Other Recent Business Highlights - PR Newswire 01.03.13 | 04:01 pm
- InterMune To Present At J. P. Morgan Healthcare Conference - PR Newswire 01.02.13 | 08:01 am
- InterMune To Release Third Quarter Financial Results On November 7 - PR Newswire 10.31.12 | 08:10 am
- Health Canada Approves Esbriet® As First Treatment For Fatal Lung Disease - PR Newswire 10.02.12 | 04:10 pm
Partner Headlines for ITMN
- Healthcare: Big pharma, big data - Financial Times 04.04.13 | 05:04 pm
- SAC signals further action after $614m deal - Financial Times 03.18.13 | 09:03 pm
- Four Biotech Stocks On The Clock - Seeking Alpha 02.19.13 | 09:02 am
- US authorities widen SAC Capital probe - Financial Times 02.13.13 | 10:02 pm
- 3 High Beta Liquid Small-Cap Biotechnology Stocks That Are Breaking Out - Seeking Alpha 09.17.12 | 09:09 am
- French Reimbursement for Esbriet - Analyst Blog - NASDAQ 09.13.12 | 09:09 pm
- Positive RECAP for ITMN's Esbriet - Analyst Blog - NASDAQ 09.04.12 | 07:09 pm
- InterMune Reports New Analyses from the RECAP Study of Esbriet at ERS - Benzinga 09.03.12 | 11:09 am
- InterMune Earnings Call NUGGETS: Patient Growth, Esbriet on the Path to Success - Wall St. Cheat Sheet 07.25.12 | 01:07 pm
- RadioShack SLIDES to Sell and 4 Anayst-Downgraded Shares - Wall St. Cheat Sheet 07.24.12 | 04:07 am
